PE anti-SPI1 (PU.1) [7C2C34]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471987
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $226.10
About this award
BioLegend Inc. has been awarded a contract by the University of Virginia to supply PE anti-SPI1 (PU.1) [7C2C34], a specialized research reagent. The contract, identified as A207_PO-0471987, was executed on August 21, 2026, with a total contract value of $226. The single line item specifies delivery of one unit of the PE (phycoerythrin) conjugated anti-SPI1 monoclonal antibody, priced at $226.10 per unit, to be delivered to Charles Mitchell Boudreaux at the University of Virginia in Virginia.
This contract represents a procurement of laboratory supplies for research purposes by a Virginia state institution. As a prime contractor award, BioLegend Inc. is directly responsible for fulfilling the delivery obligation. The modest contract value and single-unit quantity indicate this is a routine procurement of a specialized immunological reagent for ongoing research activities at the University of Virginia. No specific period of performance dates are documented in the available contract information.
Line items
| Item | Total |
|---|---|
| PE anti-SPI1 (PU.1) [7C2C34] | $226.10 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471987?
Contract A207_PO-0471987 was awarded to BIOLEGEND INC. by University of Virginia on August 21, 2026.
How much is contract A207_PO-0471987 worth?
Its cumulative value is $226.10.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award